URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer cocktail trial seeks safe dose for tough tumors
Disease control OngoingThis early-phase study aims to find the safest dose of a three-drug combination (bortezomib, gemcitabine, and doxorubicin) for people with advanced urothelial cancer or other solid tumors that cannot be removed by surgery. About 80 participants will receive the treatment to see h…
Matched conditions: URETHRAL CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New cocktail of 4 chemo drugs shows promise for tough bladder cancers
Disease control OngoingThis study tested a combination of four chemotherapy drugs (5-FU, leucovorin, gemcitabine, and cisplatin) in 46 people with advanced bladder or urethral cancer that had spread or could not be removed by surgery. The goal was to see how many patients' tumors shrank or disappeared.…
Matched conditions: URETHRAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Scientists dig into tumor DNA to solve immunotherapy resistance mystery
Knowledge-focused OngoingThis study looks at tumor samples from 15 people with kidney or bladder cancer whose cancer came back after immunotherapy. Researchers compare the genes and structure of the original tumor with the new growth to find clues about why the cancer became resistant. The goal is to bet…
Matched conditions: URETHRAL CANCER
Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:09 UTC